We narrowed to 460 results for: 52961

1. lentiCRISPR v2

   Plasmid

   #52961

   Purpose

   Replaces original lentiCRISPRv1 (Addgene Plasmid 49535) and produces ~10-fold higher titer virus. 3rd generation lentiviral backbone.

   Depositor

   Feng Zhang

   Publication

   Sanjana et al Nat Methods. 2014 Aug;11(8):783-4. doi:

   Inserts

   Cas9
   Puromycin resistance
   

   Use

   CRISPR and Lentiviral

   Tags

   FLAG

   Expression

   Mammalian

   Promoter

   EFS-NS

   Available since

   Availability

   Academic Institutions and Nonprofits only

   Cited by

   3707 Articles

   

   Enlarge

These results may also be relevant.

1. LENTICRISPR-UCK2_sgRNA2

   Plasmid

   #201633

   Purpose

   CRISPR/Cas9-mediated gene knock-out

   Depositor

   Alexis Jourdain, Vamsi Mootha

   Publication

   Skinner et al Nat Metab. 2023 May;5(5):765-776. doi: 1

   Insert

   UCK2 (UCK2 Human)
   

   Use

   CRISPR and Lentiviral

   Available since

   July 26, 2023

   Availability

   Academic Institutions and Nonprofits only

   

   Enlarge

2. LENTICRISPR-SNRPA_sgRNA1

   Plasmid

   #201622

   Purpose

   CRISPR/Cas9-mediated gene knock-out

   Depositor

   Alexis Jourdain, Vamsi Mootha

   Publication

   Jourdain et al Mol Cell. 2021 May 6;81(9):1905-1919.e12

   Insert

   SNRPA (SNRPA Human)
   

   Use

   CRISPR and Lentiviral

   Available since

   June 22, 2023

   Availability

   Academic Institutions and Nonprofits only

   

   Enlarge

3. LENTICRISPR-SNRPA_sgRNA2

   Plasmid

   #201623

   Purpose

   CRISPR/Cas9-mediated gene knock-out

   Depositor

   Alexis Jourdain, Vamsi Mootha

   Publication

   Jourdain et al Mol Cell. 2021 May 6;81(9):1905-1919.e12

   Insert

   SNRPA (SNRPA Human)
   

   Use

   CRISPR and Lentiviral

   Available since

   June 22, 2023

   Availability

   Academic Institutions and Nonprofits only

   

   Enlarge

4. LENTICRISPR-UCK2_sgRNA1

   Plasmid

   #201632

   Purpose

   CRISPR/Cas9-mediated gene knock-out

   Depositor

   Alexis Jourdain, Vamsi Mootha

   Publication

   Skinner et al Nat Metab. 2023 May;5(5):765-776. doi: 1

   Insert

   UCK2 (UCK2 Human)
   

   Use

   CRISPR and Lentiviral

   Available since

   June 22, 2023

   Availability

   Academic Institutions and Nonprofits only

   

   Enlarge

5. pLentiCRISPR v2 PC sg1

   Plasmid

   #258098

   Purpose

   Knockout

   Depositor

   Alexis Jourdain

   Publication

   Lisci et al Mol Cell. 2026 Mar 5;86(5):901-916.e10.

   Insert

   PC (PC Human)
   

   Use

   CRISPR and Lentiviral

   Promoter

   U6

   Available since

   Aug. 10, 2026

   Availability

   Academic Institutions and Nonprofits only

   

   Enlarge

6. lentiCRISPR v2-sgFDX1-2

   Plasmid

   #251680

   Purpose

   gRNA to knock out FDX1 in mammalian cells

   Depositor

   Boyi Gan

   Publication

   Lei et al Cancer Cell. 2025 Jun 9;43(6):1076-1092.

   Insert

   FDX1 ferredoxin 1 (FDX1 Human)
   

   Use

   CRISPR and Lentiviral

   Available since

   Feb. 18, 2026

   Availability

   Academic Institutions and Nonprofits only

   

   Enlarge

7. lentiCRISPR v2-sgFDX1-1

   Plasmid

   #251679

   Purpose

   gRNA to knock out FDX1 in mammalian cells

   Depositor

   Boyi Gan

   Publication

   Lei et al Cancer Cell. 2025 Jun 9;43(6):1076-1092.

   Insert

   FDX1 ferredoxin 1 (FDX1 Human)
   

   Use

   CRISPR and Lentiviral

   Available since

   Feb. 3, 2026

   Availability

   Academic Institutions and Nonprofits only

   

   Enlarge

8. LentiCRISPRv2-ACTB-C4

   Plasmid

   #229849

   Purpose

   Expresses wild-type Cas9 and gRNA for ACTB gene. The target sequence is changed from ACTB-C1 to improve the cut efficiency.

   Depositor

   Natsuko Chiba

   Insert

   guide RNA for ACTB gene
   

   Use

   CRISPR and Lentiviral

   Expression

   Mammalian

   Available since

   Feb. 20, 2025

   Availability

   Academic Institutions and Nonprofits only

   Cited by

   1 Article

   

   Enlarge

9. pLentiCriprV2-sgRNA-CRY2-#1

   Plasmid

   #189989

   Purpose

   Lentiviral Cas9/sgRNA vector targeting C-terminus of hCRY2, works with Addgene 189983-189986

   Depositor

   Achim Kramer

   Publication

   Gabriel et al Proc Natl Acad Sci U S A. 2024 Aug 20;12

   Insert

   Cryptochrome-2 (CRY2 Human)
   

   Use

   CRISPR and Lentiviral

   Available since

   Feb. 9, 2024

   Availability

   Academic Institutions and Nonprofits only

   

   Enlarge

10. LENTICRISPR-LUC7L2_sgRNA1

    Plasmid

    #201602

    Purpose

    CRISPR/Cas9-mediated gene knock-out

    Depositor

    Alexis Jourdain, Vamsi Mootha

    Publication

    Jourdain et al Mol Cell. 2021 May 6;81(9):1905-1919.e12

    Insert

    LUC7L2 (LUC7L2 Human)
    

    Use

    CRISPR and Lentiviral

    Available since

    Dec. 8, 2023

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge

11. LENTICRISPR-TYMS_sgRNA2

    Plasmid

    #201629

    Purpose

    CRISPR/Cas9-mediated gene knock-out

    Depositor

    Alexis Jourdain, Vamsi Mootha

    Publication

    Skinner et al Nat Metab. 2023 May;5(5):765-776. doi: 1

    Insert

    TYMS (TYMS Human)
    

    Use

    CRISPR and Lentiviral

    Available since

    June 22, 2023

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge

12. LENTICRISPR-ACIN1_sgRNA1

    Plasmid

    #201588

    Purpose

    CRISPR/Cas9-mediated gene knock-out

    Depositor

    Alexis Jourdain, Vamsi Mootha

    Publication

    Jourdain et al Mol Cell. 2021 May 6;81(9):1905-1919.e12

    Insert

    ACIN1 (ACIN1 Human)
    

    Use

    CRISPR and Lentiviral

    Available since

    June 22, 2023

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge

13. LENTICRISPR-ACIN1_sgRNA2

    Plasmid

    #201589

    Purpose

    CRISPR/Cas9-mediated gene knock-out

    Depositor

    Alexis Jourdain, Vamsi Mootha

    Publication

    Jourdain et al Mol Cell. 2021 May 6;81(9):1905-1919.e12

    Insert

    ACIN1 (ACIN1 Human)
    

    Use

    CRISPR and Lentiviral

    Available since

    June 22, 2023

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge

14. LENTICRISPR-LUC7L_sgRNA1

    Plasmid

    #201600

    Purpose

    CRISPR/Cas9-mediated gene knock-out

    Depositor

    Alexis Jourdain, Vamsi Mootha

    Publication

    Jourdain et al Mol Cell. 2021 May 6;81(9):1905-1919.e12

    Insert

    LUC7L (LUC7L Human)
    

    Use

    CRISPR and Lentiviral

    Available since

    June 22, 2023

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge

15. LENTICRISPR-LUC7L_sgRNA2

    Plasmid

    #201601

    Purpose

    CRISPR/Cas9-mediated gene knock-out

    Depositor

    Alexis Jourdain, Vamsi Mootha

    Publication

    Jourdain et al Mol Cell. 2021 May 6;81(9):1905-1919.e12

    Insert

    LUC7L (LUC7L Human)
    

    Use

    CRISPR and Lentiviral

    Available since

    June 22, 2023

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge

16. LENTICRISPR-LUC7L2_sgRNA2

    Plasmid

    #201603

    Purpose

    CRISPR/Cas9-mediated gene knock-out

    Depositor

    Alexis Jourdain, Vamsi Mootha

    Publication

    Jourdain et al Mol Cell. 2021 May 6;81(9):1905-1919.e12

    Insert

    LUC7L2 (LUC7L2 Human)
    

    Use

    CRISPR and Lentiviral

    Available since

    June 22, 2023

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge

17. LentiCRISPRv2-puro-dEgfr

    Plasmid

    #173844

    Purpose

    A knockout vector for the dog Egfr.

    Depositor

    Michiyuki Matsuda

    Publication

    Lin et al Life Sci Alliance. 2021 Oct 19;5(1). pii

    Insert

    A gRNA targeting the dog Egfr gene and the cDNA of CRISPR-Cas9
    

    Use

    CRISPR and Lentiviral

    Available since

    Oct. 21, 2021

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge

18. LCV2_AAVS1_sgRNA_4

    Plasmid

    #155090

    Purpose

    lentiviral plasmid expressing Cas9 and gRNA targeting AAVS1 safe harbor locus

    Depositor

    Jason Moffat

    Publication

    Aregger et al Nat Metab. 2020 Jun;2(6):499-513. doi: 1

    Insert

    AAVS1_sgRNA_4
    

    Use

    CRISPR and Lentiviral

    Expression

    Mammalian

    Promoter

    U6 promoter

    Available since

    Aug. 7, 2020

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge

19. pLENTICRISPR v2 UMPS sg1

    Plasmid

    #258049

    Purpose

    Knockout

    Depositor

    Alexis Jourdain

    Publication

    Strefeler et al Nat Metab. 2025 Nov;7(11):2221-2235. doi

    Insert

    UMPS (UMPS Human)
    

    Use

    CRISPR and Lentiviral

    Available since

    Aug. 28, 2026

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge

20. pLentiCRISPR v2 PPP1R18 sg2

    Plasmid

    #258072

    Purpose

    Knockout

    Depositor

    Alexis Jourdain

    Publication

    Strefeler et al Nat Metab. 2025 Nov;7(11):2221-2235. doi

    Insert

    PPP1R18 (KIAA1949 Human)
    

    Use

    CRISPR and Lentiviral

    Available since

    Aug. 19, 2026

    Availability

    Academic Institutions and Nonprofits only

    

    Enlarge